These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23030601)

  • 1. Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.
    Olsson SK; Sellgren C; Engberg G; Landén M; Erhardt S
    Bipolar Disord; 2012 Nov; 14(7):719-26. PubMed ID: 23030601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
    Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
    Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
    Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.
    Atlas A; Gisslén M; Nordin C; Lindström L; Schwieler L
    Brain Behav Immun; 2007 Jan; 21(1):86-91. PubMed ID: 16603336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.
    Olsson SK; Samuelsson M; Saetre P; Lindström L; Jönsson EG; Nordin C; Engberg G; Erhardt S; Landén M
    J Psychiatry Neurosci; 2010 May; 35(3):195-9. PubMed ID: 20420770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
    Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
    Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls.
    Sellgren CM; Gracias J; Jungholm O; Perlis RH; Engberg G; Schwieler L; Landen M; Erhardt S
    Transl Psychiatry; 2019 Jan; 9(1):37. PubMed ID: 30696814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis.
    Holtze M; Mickiené A; Atlas A; Lindquist L; Schwieler L
    J Intern Med; 2012 Oct; 272(4):394-401. PubMed ID: 22443218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
    Sellgren CM; Kegel ME; Bergen SE; Ekman CJ; Olsson S; Larsson M; Vawter MP; Backlund L; Sullivan PF; Sklar P; Smoller JW; Magnusson PK; Hultman CM; Walther-Jallow L; Svensson CI; Lichtenstein P; Schalling M; Engberg G; Erhardt S; Landén M
    Mol Psychiatry; 2016 Oct; 21(10):1342-50. PubMed ID: 26666201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
    Nilsson LK; Linderholm KR; Engberg G; Paulson L; Blennow K; Lindström LH; Nordin C; Karanti A; Persson P; Erhardt S
    Schizophr Res; 2005 Dec; 80(2-3):315-22. PubMed ID: 16125901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Jönsson EG; Erhardt S; Nordström P
    Psychiatry Res; 2013 Jan; 205(1-2):165-7. PubMed ID: 22980480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarity at illness onset in bipolar I disorder and clinical course of illness.
    Forty L; Jones L; Jones I; Smith DJ; Caesar S; Fraser C; Gordon-Smith K; Hyde S; Craddock N
    Bipolar Disord; 2009 Feb; 11(1):82-8. PubMed ID: 19133970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
    Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
    Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Dulay JR; Weis S
    Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotic features in bipolar and unipolar depression.
    Goes FS; Sadler B; Toolan J; Zamoiski RD; Mondimore FM; Mackinnon DF; Schweizer B; ; Raymond Depaulo J; Potash JB
    Bipolar Disord; 2007 Dec; 9(8):901-6. PubMed ID: 18076541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics.
    van der Werf-Eldering MJ; van der Meer L; Burger H; Holthausen EA; Nolen WA; Aleman A
    Bipolar Disord; 2011 Jun; 13(4):343-54. PubMed ID: 21843274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained attention deficits in manic and euthymic patients with bipolar disorder.
    Bora E; Vahip S; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1097-102. PubMed ID: 16740350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
    Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.